Peptides for joint pain and arthritis: do they work?
BPC-157 and TB-500 are not FDA approved. Proof in people is very thin.
By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Not yet reviewed by a licensed clinician. How we check facts

Can peptides help with arthritis?
- Not in a proven way yet. No peptide is FDA approved to treat arthritis or joint pain.
- We look at 3 things on their own: FDA status, proof that it works, and safety. A peptide can have little safety data and still work, or not. We just do not know yet.
- The peptides people talk about most for joints are BPC-157 and TB-500. Both are sold online as "research" products. Neither is an approved medicine.
Is BPC-157 good for arthritis or joint pain?
- Nobody knows yet. Only 3 small studies in people have been published.
- In the biggest one, a clinic called 16 people who got BPC-157 shots in the knee. 14 of them said their knee pain got better. There was no comparison group, and 4 people also got TB-4.
- A 2026 review of all human BPC-157 studies found just 30 people in total. It said the studies were poor quality and the proof is "very low."
- A study of BPC-157 after rotator cuff (shoulder) surgery is listed but not yet recruiting. A hamstring study is recruiting.
- FDA status: not approved. In April 2026 the FDA took BPC-157 off its list of risky ingredients (Category 2). It is not on the list regular pharmacies may use, but since October 28, 2026, an interim HHS policy covers pharmacy-made BPC-157 with a prescription.
Does TB-500 help joints or tendons?
- We found no published study of TB-500 in people for joints, tendons or anything else.
- The first TB-500 study in people that we found is about heart blood markers. It is still recruiting.
- Animal and lab results do not tell us what happens in people.
Do collagen peptides help joint pain?
- A little, maybe. Collagen peptides are bits of protein from animal skin or bone, sold as powders and pills.
- A review of 11 trials with 870 people with knee arthritis found less pain and better movement than placebo. But results changed a lot from study to study.
- An older review found the total arthritis score got better, but the pain part alone did not change enough to count.
- Collagen is sold as a supplement. The FDA does not approve supplements before they are sold.
Can Wegovy or Ozempic help knee pain?
- For people with obesity and knee arthritis, one big trial says yes. It was called STEP 9.
- 407 adults took the semaglutide shot used in Wegovy, or a fake shot, for 68 weeks. Weight went down 13.7% vs 3.2%.
- Knee pain scores dropped 41.7 points on semaglutide vs 27.5 points on the fake shot (on a 100-point scale).
- More people stopped semaglutide because of side effects, 6.7% vs 3.0%, mostly stomach problems. The drug maker paid for the trial.
- Semaglutide is FDA approved for weight and other uses, but not for arthritis.
What actually helps arthritis pain?
- The NIH arthritis institute (NIAMS) lists treatments with real track records: exercise, weight loss if needed, heat and cold, braces or canes, and physical therapy.
- Medicines it lists include pain relievers you take by mouth, creams you rub on, steroid shots, and hyaluronic acid shots for knees.
- When pain is severe, joint replacement surgery is an option.
- Doctors who treat arthritis include rheumatologists, orthopaedic surgeons and physical therapists.
Are peptides allowed in sports?
- Many athletes get tested. BPC-157 is banned in sports as a drug that is not approved anywhere.
- Starting January 1, 2027, the world anti-doping list (WADA) will name "peptides" in that same group.
- Use our drug test tool to check a peptide before you compete.
The numbers in charts
Semaglutide and knee pain (STEP 9)
407 adults with obesity and knee arthritis, 68 weeks
Drop in knee pain scoreWOMAC pain, 0–100 scale
Weight lost% of starting weight
Knee pain dropped more with semaglutide. Pain also dropped a lot on placebo.
Show the numbers as a table
| Measure | Semaglutide 2.4 mg | Placebo |
|---|---|---|
| Drop in knee pain score WOMAC pain, 0–100 scale | −41.7 points | −27.5 points |
| Weight lost % of starting weight | −13.7% | −3.2% |
Every BPC-157 study in people, added up
30 people in 3 small studies. None compared it with a placebo
People in BPC-157 studiesA 2026 review found these 3 studies
- Knee pain chart review 16
- Bladder pain pilot 12
- Safety pilot (IV) 2
30 people total. For comparison, the semaglutide SELECT heart trial had 17,604 people.
Show the numbers as a table
| All human studies | Knee pain chart review | Bladder pain pilot | Safety pilot (IV) | Total |
|---|---|---|---|---|
| People in BPC-157 studies | 16 | 12 | 2 | 30 |
Collagen reviews: how many people in each
People in 4 big reviews of collagen supplement trials
Skin review, 2025 (23 trials)Trials NOT paid for by companies showed no clear skin benefit
Skin review, 2021 (19 trials)Found better skin moisture and stretch
Joint pain review, 2025 (11 trials)Found less pain and stiffness
Bigger is not always better: the 2025 skin review found the benefit only in company-paid and lower-quality trials.
Show the numbers as a table
| Review | People |
|---|---|
| Skin review, 2025 (23 trials) Trials NOT paid for by companies showed no clear skin benefit | 1,474 |
| Skin review, 2021 (19 trials) Found better skin moisture and stretch | 1,125 |
| Joint pain review, 2025 (11 trials) Found less pain and stiffness | 870 |
Studies in people
| Study type | People | Main finding | Limits |
|---|---|---|---|
| Randomized trial: semaglutide vs placebo (STEP 9), 2024 | 407 adults with obesity and knee arthritis | Knee pain score fell 41.7 vs 27.5 points; weight fell 13.7% vs 3.2% | 68 weeks; maker-funded; only people with obesity |
| Review of 11 randomized trials: collagen for knee arthritis, 2024/2025 | 870 people | Less pain and better movement than placebo | Results varied a lot between studies |
| Review of trials: collagen for arthritis, 2018/2019 | Several placebo-controlled trials | Total score, stiffness and a pain scale got better; the pain part of the main score did not change enough | Older, smaller review |
| Look-back chart review: BPC-157 knee shots, 2021 | 16 people | 14 of 16 said knee pain got better | No comparison group; 4 also got TB-4 |
| Review of all human studies: BPC-157, 2026 | 3 studies, 30 people | Proof rated "very low" | Poor-quality studies |
Joint pain options: FDA status, proof and safety
| FDA status | Proof it helps joints in people | Safety data | |
|---|---|---|---|
| BPC-157 | Not FDA approved | Very low: 3 tiny studies, 30 people | Very little |
| TB-500 | Not FDA approved | None published in people | None published in people |
| Collagen peptides (supplement) | Supplement; FDA does not approve these before sale | Some: small trials, mixed results | Not well reported in the reviews we read |
| GLP-1: Wegovy (semaglutide) | Approved for weight, not for arthritis | 1 big trial in people with obesity and knee arthritis | Well studied; FDA label lists risks |
| Exercise, physical therapy (not peptides) | Not a drug | Recommended by NIAMS | Generally safe; ask your doctor |
FAQ
Is BPC-157 better than a cortisone shot?
No study has compared them. Steroid shots are a standard arthritis treatment listed by NIAMS. BPC-157 is not approved.
Can a peptide regrow knee cartilage?
We found no study in people showing that any peptide regrows cartilage.
Do peptides help a torn meniscus?
We found no human trial of BPC-157 or TB-500 for meniscus tears.
Is collagen the same thing as BPC-157?
No. Collagen peptides are food proteins sold as supplements. BPC-157 is a lab-made peptide that is not an approved drug.
Should I tell my surgeon I take peptides?
Yes. Tell your doctor and surgeon about every product you use, including supplements and anything bought online.
Do peptides help dogs with arthritis?
This site covers human health only. Please ask a veterinarian.
Related pages
- BPC-157Not approved · Proof: Early
- TB-500Not approved · Proof: Animal or lab only
- GLP-1: Wegovy / Ozempic (semaglutide)FDA approved · Proof: Strong
- GLP-1: Zepbound / Mounjaro (tirzepatide)FDA approved · Proof: Strong
- GHK-CuNot approved · Proof: Early
- Thymosin alpha-1Not approved · Proof: Mixed
- Are collagen peptides the same as peptides?Guide
- Peptides for tendons and injury recovery: do they work?Guide
- Peptides for back pain and sciatica: do they work?Guide
- BPC-157 vs TB-500: What Is the Difference?Guide
- What Is the "Wolverine Stack"? (BPC-157 + TB-500)Guide
- Do peptides really work? The honest answerGuide
- Peptide side effects: what is common and what is serious?Guide
- Peptides before surgery: do you have to stop GLP-1 drugs like Ozempic?Guide
- Peptide comparison toolTool
- Do peptides show up on a drug test?Tool
- Is there a peptide for my goal?Tool
- How long do peptides take to work?Tool
- Do peptides show up on a drug test?Tool
- Compare BPC-157 vs TB-500Comparison tool
We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.
Sources
- NIAMS (NIH): Osteoarthritis diagnosis, treatment and steps to take
- PubMed: Bliddal et al., Once-weekly semaglutide in persons with obesity and knee osteoarthritis (STEP 9), NEJM 2024
- PubMed: Simental-Mendía et al., Collagen supplementation for knee osteoarthritis: updated meta-analysis of randomised trials, Clin Exp Rheumatol 2025
- PubMed: García-Coronado et al., Effect of collagen supplements on osteoarthritis symptoms: meta-analysis, Int Orthop 2019
- PubMed: Kumar et al., Undenatured type II collagen (UC-II) for knee osteoarthritis: review and meta-analysis, 2023
- PubMed: Lee & Padgett, Intra-articular injection of BPC-157 for knee pain: a look-back study, 2021
- PubMed: Poolton et al., Human evidence for BPC-157: a systematic review, Acta Orthop Belg 2026
- FDA: Bulk drug substances that may present significant safety risks (Category 2 and withdrawn list)
- FDA: Questions and answers on dietary supplements (FDA does not approve supplements before sale)
- DailyMed (FDA label): Wegovy (semaglutide) injection and tablets prescribing information, revised 6/2026
- HHS: Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (Oct 28, 2026)
- Federal Register (public inspection): FR Doc. 2026-22192, HHS peptide compounding policy